| AEREA Y POSTAL EX-IAAC | 2023 | 0.147 | KG | ERITROMICINA (USP) USP S/M ERYTHROMYCIN (250 MG) ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO LOTE: R097G0 | CHINA | UNITED STATES | 274.44 |
| MARITIMA DEL CALLAO | 2023 | 550 | KG | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-, S/M, S/M (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyr 6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2.10-d MATERIA PRIMA | THAILAND | KOREA, REPUBLIC OF | 31950 |
| AEREA Y POSTAL EX-IAAC | 2023 | 600 | KG | 5-THIA-1-AZABICYCLO [4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID,7-[(AMINOPHENYLACETYL)AMINO]-3-MET 5-THIA-1-AZABICYCLO [4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID,7-[(AMINOPHENYLACETYL)AMINO]-3-MET MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 37841 |
| AEREA Y POSTAL EX-IAAC | 2023 | 350 | KG | 5-THIA-1-AZABICYCLO [4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID,7-[(AMINOPHENYLACETYL)AMINO]-3-MET 5-THIA-1-AZABICYCLO [4.2.0] OCT-2-ENE-2-CARBOXYLIC ACID,7-[(AMINOPHENYLACETYL)AMINO]-3-MET MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 23539.5 |
| MARITIMA DEL CALLAO | 2023 | 150 | KG | 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 8505 |
| MARITIMA DEL CALLAO | 2023 | 725 | KG | 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | CHINA | CHINA | 41107.5 |
| AEREA Y POSTAL EX-IAAC | 2023 | 525 | KG | 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILIC ACID, 7-(AMINOPHENYLACETYL)AMINO)-3-METHY MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 30345 |
| AEREA Y POSTAL EX-IAAC | 2023 | 250 | KG | 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILICACID,7-(AMINOPHENYLACETYL)AMINO)-3-METHYL- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXILICACID,7-(AMINOPHENYLACETYL)AMINO)-3-METHYL- MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN | SPAIN | CHINA | 15300 |
| MARITIMA DEL CALLAO | 2023 | 1500 | KG | CEFALEXINA MONOHIDRATADA S/M S/M CEFALEXIN MONOHYDRATE MATERIA PRIMA PARA LA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KILOGRAMOS | SPAIN | SPAIN | 89105 |
| AEREA Y POSTAL EX-IAAC | 2023 | 20 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3- [(2S,3S)-3-hydroxybutan-2-yl]oxiran-2 oxan-2-yl]-3-mehylbut-2-enoyl]oxynonanoic acid S/M S/M COMERCIALIZADO EN KG MATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS | CHINA | CHINA | 10435 |
| AEREA Y POSTAL EX-IAAC | 2023 | 40 | KG | CALCIUM;9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2s,3s)-3-HYDROXYBUTAN-2-Yl]O CALCIUM;9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]O MATERIA PRIMA PARA FABRICACIÓN DE MEDICAMENTOS COMERCIALIZADO EN KG | CHINA | CHINA | 52364 |
| AEREA Y POSTAL EX-IAAC | 2023 | 20 | KG | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- 9-[(E)-4-[(2S,3R,4R,5S)-3,4-DIHYDROXY-5-[[(2S,3S)-3-[(2S,3S)-3-HYDROXYBUTAN-2-YL]OXIRAN-2- MAATERIA PRIMA PARA FABRICACION DE MEDICAMENTOS COMERCIALIZADO EN KI | CHINA | CHINA | 10645 |